Rare diseases
Investigational molecules
Locations
Back to Czechia22 clinical trials in Hlucin, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CzechiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CzechiaStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
CzechiaEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
CzechiaStudy on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
CzechiaStudy on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis
CzechiaStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
CzechiaA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
CzechiaA study testing SPY072 compared to placebo in adults with moderately to severely active rheumatologic disease
CzechiaStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Not Used Biologic Treatments
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on psoriatic arthritis and rheumatoid arthritis treatments, including evaluation of novel therapies like zasocitinib and biosimilar medications.
Multiple trials examining both biologic-experienced and biologic-naïve patient populations.
Innovative studies targeting cardiovascular disease and hypercholesterolemia, with particular focus on lipoprotein management and prevention of major cardiac events.
Research aims to evaluate new approaches for reducing cardiovascular risks and improving patient outcomes.
Studies addressing various inflammatory conditions including polymyalgia rheumatica and gout, testing new therapeutic approaches and treatment combinations.
Trials focus on both immediate symptom relief and long-term disease management strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
